Under a USD 2.7 million Medical Research Future Fund (MRFF) grant, UQ developed an exosome-based blood test for early ovarian cancer detection. INOVIQ provided its EXO-NET® technology for fast ...

Exosome-based diagnostics offer the advantage of being minimally invasive, as they can be detected in bodily fluids like blood, urine, or saliva, making them a promising tool for early detection ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

A comprehensive review has explored the diverse roles of extracellular vesicles (EVs) in the oral and maxillofacial region, highlighting their immense ...

Additionally, establishing more sensitive means to identify LAT1 on exosomes could also improve its detection at lower volumes of exosomes, like in the blood and during the early stages of cancer ...

Cancer is a leading cause of death worldwide but several ASX biotechs are focused on early detection and treatment to ... Read More The post The ASX biotechs aiming to catch cancer early appeared ...

ABU DHABI, UAE/PRNewswire/ -- DNA Health & Wellness, the UAE's leading health optimisation and longevity clinic group, is ...

Rapid detection of diverse biomarkers is crucial ... Here the authors reveal ginger-derived exosome-like nanoparticle (GELN) aly-miR159a-3p enhances anti-PD-L1 therapy by increasing microbiota ...

Bioanalytical Testing Services Market size is expected to reach USD 9.0 billion by 2033, achieving a compound annual growth rate (CAGR) of 9.8%.

Abstract: Exosomes that contain TSG101 biomarkers are synthesized ... We achieved a linear response, specifically at concentrations ranging from 0.125 to 8 ng/mL, with a detection limit of 0.10 ng/mL ...